NCT04214262 2026-03-18
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Emory University
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
UNICANCER
Hoosier Cancer Research Network
VA Office of Research and Development